Tomoya Tateishi Selected Research

Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)

1/2022	Successful diagnosis of humidifier lung by individual provocation test to a responsible environment, a case report.
11/2020	Changes in serum KL-6 levels during short-term strict antigen avoidance are associated with the prognosis of patients with fibrotic hypersensitivity pneumonitis caused by avian antigens.
7/2019	Periostin as a predictor of prognosis in chronic bird-related hypersensitivity pneumonitis.
7/2019	Acute inflammatory and immunologic responses against antigen in chronic bird-related hypersensitivity pneumonitis.
4/2019	The Analysis of Surgical Lung Biopsy and Explanted Lung Specimens Sheds Light on the Pathological Progression of Chronic Bird-related Hypersensitivity Pneumonitis.
1/2019	Serum CXCL9 and CCL17 as biomarkers of declining pulmonary function in chronic bird-related hypersensitivity pneumonitis.
1/2018	[A CASE OF ACUTE EXACERBATION OF CHRONIC BIRDRELATED HYPERSENSITIVITY PNEUMONITIS WITH A REMARKABLE ELEVATION OF ENVIRONMENTAL AVIAN ANTIGEN LEVELS].
1/2016	Chronic Hypersensitivity Pneumonitis With a Usual Interstitial Pneumonia-Like Pattern: Correlation Between Histopathologic and Clinical Findings.
9/2015	Antigen avoidance tests for diagnosis of chronic hypersensitivity pneumonitis.
2/2015	Validation of inhalation provocation test in chronic bird-related hypersensitivity pneumonitis and new prediction score.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoya Tateishi Research Topics

Disease

13	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2022 - 03/2011
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 09/2015
4	Lung Diseases (Lung Disease) 02/2020 - 01/2015
2	COVID-19 09/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2021 - 02/2020
2	Idiopathic Pulmonary Fibrosis 07/2019 - 12/2008
2	Inflammation (Inflammations) 07/2019 - 01/2015
2	Pneumonia (Pneumonitis) 07/2019 - 01/2015
1	Hypertension (High Blood Pressure) 06/2021
1	Hemorrhage 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2020
1	Pneumoconiosis 02/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2019
1	Fibrosis (Cirrhosis) 07/2019
1	Idiopathic Interstitial Pneumonias 07/2019
1	Disease Progression 04/2019
1	Emphysema 12/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2018
1	Dyspnea (Shortness of Breath) 01/2018
1	Bronchiectasis 01/2016
1	Connective Tissue Diseases (Connective Tissue Disease) 09/2015
1	Vascular Diseases (Vascular Disease) 09/2015
1	Granuloma 01/2015
1	Bird Fancier's Lung 12/2008

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 01/2022 - 03/2011
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
3	CytokinesIBA 07/2019 - 05/2013
2	fibrin fragment D (D-dimer)IBA 06/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 02/2020 - 01/2020
2	ChemokinesIBA 07/2019 - 05/2013
1	A-factor (Streptomyces)IBA 09/2022
1	RNA (Ribonucleic Acid)IBA 09/2022
1	Ferritins (Ferritin)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	CosmeticsIBA 02/2020
1	MetalsIBA 02/2020
1	TitaniumIBA 02/2020
1	titanium dioxide (Titania)FDA Link 02/2020
1	NivolumabIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Carbon MonoxideIBA 07/2019
1	PeriostinIBA 07/2019
1	Matrix Metalloproteinases (MMPs)IBA 12/2018
1	Pancreatic Elastase (Elastase)IBA 12/2018
1	Interleukin-4 (Interleukin 4)IBA 12/2018
1	AntibodiesIBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	CollagenIBA 09/2015
1	Interleukin-17 (Interleukin 17)IBA 01/2015
1	LigandsIBA 01/2015
1	CXC ChemokinesIBA 01/2015
1	Methylcellulose (BFL)IBA 12/2008

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 02/2020 - 01/2020
1	Humidifiers 01/2022
1	Lung Transplantation 04/2019
1	Traction 01/2016